{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T20:08:07Z","timestamp":1784837287932,"version":"3.55.0"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,9,10]],"date-time":"2024-09-10T00:00:00Z","timestamp":1725926400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,9,10]],"date-time":"2024-09-10T00:00:00Z","timestamp":1725926400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Neurol"],"DOI":"10.1186\/s12883-024-03837-3","type":"journal-article","created":{"date-parts":[[2024,9,10]],"date-time":"2024-09-10T07:02:42Z","timestamp":1725951762000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Further insights into anti-IgLON5 disease: a case with complex clinical presentation"],"prefix":"10.1186","volume":"24","author":[{"given":"Simone","family":"Pierro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federico","family":"Verde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessio","family":"Maranzano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"De Gobbi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleonora","family":"Colombo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Doretti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Messina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Maderna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonia","family":"Ratti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Floriano","family":"Girotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Andreetta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincenzo","family":"Silani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Morelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"Ticozzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,9,10]]},"reference":[{"key":"3837_CR1","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/S1474-4422(15)00401-9","volume":"15","author":"F Graus","year":"2016","unstructured":"Graus F, Titulaer MJ, Balu R, Benseler S, Bien CG, Cellucci T, et al. A clinical approach to diagnosis of autoimmune encephalitis. Lancet Neurol. 2016;15:391\u2013404.","journal-title":"Lancet Neurol"},{"key":"3837_CR2","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1001\/jamaneurol.2022.4251","volume":"80","author":"EP Flanagan","year":"2023","unstructured":"Flanagan EP, Geschwind MD, Lopez-Chiriboga AS, Blackburn KM, Turaga S, Binks S, et al. Autoimmune encephalitis misdiagnosis in adults. JAMA Neurol. 2023;80:30\u20139.","journal-title":"JAMA Neurol"},{"key":"3837_CR3","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1056\/NEJMra1708712","volume":"378","author":"J Dalmau","year":"2018","unstructured":"Dalmau J, Graus F. Antibody-mediated encephalitis. N Engl J Med. 2018;378:840\u201351.","journal-title":"N Engl J Med"},{"key":"3837_CR4","doi-asserted-by":"crossref","unstructured":"Madetko N, Marzec W, Kowalska A, Przewodowska D, Alster P, Koziorowski D. Anti-IgLON5 disease - the current state of knowledge and further perspectives. Front Immunol. 2022:13:852215.","DOI":"10.3389\/fimmu.2022.852215"},{"key":"3837_CR5","doi-asserted-by":"crossref","unstructured":"Honorat JA, Komorowski L, Josephs KA, Fechner K, St Louis EK, Hinson SR, et al. IgLON5 antibody: Neurological accompaniments and outcomes in 20 patients. Neurol Neuroimmunol Neuroinflamm. 2017;4:e385.","DOI":"10.1212\/NXI.0000000000000385"},{"key":"3837_CR6","doi-asserted-by":"crossref","unstructured":"Gaig C, Graus F, Compta Y, H\u00f6gl B, Bataller L, Br\u00fcggemann N, et al. Clinical manifestations of the anti-IgLON5 disease. Neurology. 2017;88:1736\u201343.","DOI":"10.1212\/WNL.0000000000003887"},{"key":"3837_CR7","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1002\/mds.26093","volume":"30","author":"JF Baizabal-Carvallo","year":"2015","unstructured":"Baizabal-Carvallo JF, Cardoso F, Jankovic J. Myorhythmia: phenomenology, etiology, and treatment. Mov Disord. 2015;30:171\u20139.","journal-title":"Mov Disord"},{"key":"3837_CR8","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/S1474-4422(14)70051-1","volume":"13","author":"L Sabater","year":"2014","unstructured":"Sabater L, Gaig C, Gelpi E, Bataller L, Lewerenz J, Torres-Vega E, et al. A novel non-rapid-eye movement and rapid-eye-movement parasomnia with sleep breathing disorder associated with antibodies to IgLON5: a case series, characterisation of the antigen, and post-mortem study. Lancet Neurol. 2014;13:575\u201386.","journal-title":"Lancet Neurol"},{"key":"3837_CR9","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.jns.2017.01.048","volume":"377","author":"R El-Abassi","year":"2017","unstructured":"El-Abassi R, Soliman MY, Williams F, England JD. Whipple\u2019s disease. J Neurol Sci. 2017;377:197\u2013206.","journal-title":"J Neurol Sci"},{"key":"3837_CR10","doi-asserted-by":"publisher","first-page":"3417","DOI":"10.1111\/ene.15511","volume":"30","author":"J Mecklenburg","year":"2023","unstructured":"Mecklenburg J, Moos V, Moter A, Siebert E, Nave AH, Schneider T, et al. The spectrum of central nervous system involvement in Whipple\u2019s disease. Eur J Neurol. 2023;30:3417\u201329.","journal-title":"Eur J Neurol"},{"key":"3837_CR11","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1093\/brain\/awac090","volume":"146","author":"T Gr\u00fcter","year":"2023","unstructured":"Gr\u00fcter T, M\u00f6llers FE, Tietz A, Dargvainiene J, Melzer N, Heidbreder A, et al. Clinical, serological and genetic predictors of response to immunotherapy in anti-IgLON5 disease. Brain. 2023;146:600\u201311.","journal-title":"Brain"},{"key":"3837_CR12","doi-asserted-by":"crossref","unstructured":"Werner J, Jelcic I, Schwarz EI, Probst-M\u00fcller E, Nilsson J, Schwizer B, et al. Anti-IgLON5 disease: a new bulbar-onset motor neuron mimic syndrome. Neurol Neuroimmunol Neuroinflamm. 2021;8:e962.","DOI":"10.1212\/NXI.0000000000000962"},{"key":"3837_CR13","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1007\/s00401-016-1591-8","volume":"132","author":"E Gelpi","year":"2016","unstructured":"Gelpi E, H\u00f6ftberger R, Graus F, Ling H, Holton JL, Dawson T, et al. Neuropathological criteria of anti-IgLON5-related tauopathy. Acta Neuropathol. 2016;132:531\u201343.","journal-title":"Acta Neuropathol"},{"key":"3837_CR14","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1007\/s00401-023-02625-6","volume":"146","author":"E Berger-Sieczkowski","year":"2023","unstructured":"Berger-Sieczkowski E, Endmayr V, Haider C, Ricken G, Jauk P, Macher S, et al. Analysis of inflammatory markers and tau deposits in an autopsy series of nine patients with anti-IgLON5 disease. Acta Neuropathol. 2023;146:631\u201345.","journal-title":"Acta Neuropathol"},{"key":"3837_CR15","doi-asserted-by":"crossref","unstructured":"Chung DC, Roemer S, Petrucelli L, Dickson DW. Cellular and pathological heterogeneity of primary tauopathies. Mol Neurodegener. 2021;16:57.","DOI":"10.1186\/s13024-021-00476-x"},{"key":"3837_CR16","doi-asserted-by":"crossref","unstructured":"Ryding M, Gamre M, Nissen MS, Nilsson AC, Okarmus J, Poulsen AAE, et al. Neurodegeneration induced by anti-IgLON5 antibodies studied in induced pluripotent stem cell-derived human neurons. Cells. 2021;10:837.","DOI":"10.3390\/cells10040837"},{"key":"3837_CR17","doi-asserted-by":"crossref","unstructured":"Erro ME, Sabater L, Mart\u00ednez L, Herrera M, Ostolaza A, Garc\u00eda de Gurtubay I, et al. Anti-IGLON5 disease: a new case without neuropathologic evidence of brainstem tauopathy. Neurol Neuroimmunol Neuroinflamm. 2019;7:e651.","DOI":"10.1212\/NXI.0000000000000651"},{"key":"3837_CR18","doi-asserted-by":"publisher","first-page":"e200234","DOI":"10.1212\/NXI.0000000000200234","volume":"11","author":"SY Lee","year":"2024","unstructured":"Lee SY, Shoji H, Shimozawa A, Aoyagi H, Sato Y, Tsumagari K, et al. Phenotypic insights into anti-IgLON5 disease in IgLON5-deficient mice. Neurol Neuroimmunol Neuroinflamm. 2024;11:e200234.","journal-title":"Neurology(R) Neuroimmunol Neuroinflammation"},{"key":"3837_CR19","doi-asserted-by":"crossref","unstructured":"Sabater L, Planagum\u00e0 J, Dalmau J, Graus F. Cellular investigations with human antibodies associated with the anti-IgLON5 syndrome. J Neuroinflammation. 2016;13:226.","DOI":"10.1186\/s12974-016-0689-1"},{"key":"3837_CR20","doi-asserted-by":"crossref","unstructured":"Nissen MS, Blaabjerg M. Anti-IgLON5 disease: a case with 11-year clinical course and review of the literature. Front Neurol. 2019;10:1056.","DOI":"10.3389\/fneur.2019.01056"}],"container-title":["BMC Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-024-03837-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12883-024-03837-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-024-03837-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,10]],"date-time":"2024-09-10T19:04:41Z","timestamp":1725995081000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcneurol.biomedcentral.com\/articles\/10.1186\/s12883-024-03837-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,10]]},"references-count":20,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["3837"],"URL":"https:\/\/doi.org\/10.1186\/s12883-024-03837-3","relation":{},"ISSN":["1471-2377"],"issn-type":[{"value":"1471-2377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,10]]},"assertion":[{"value":"21 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 August 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 September 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Ethics Committee of IRCCS Istituto Auxologico Italiano (project DAMARE, code 2021_05_18_04). The study is in accordance with the declaration of Helsinki. The patient provided consent to publication of the case.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was acquired from the patient described within the present study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The wife (caregiver) of the patient provided written informed consent to publish on his behalf.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publish"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"334"}}